insights_auto
Why is GENB up 3,90%?
Dive Deeperchevron_right
GENB:NASDAQ
Generate Biomedicines Inc
13,06 US$
arrow_upward
+3,90%(+0,49) 1D
6 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GENB...
Open
12,90 US$
High
13,17 US$
Low
12,47 US$
Mkt. cap
1,68 მლრდ.
Avg. vol.
1,04 მლნ.
Volume
632,20 ათ.
52-wk high
22,67 US$
52-wk low
11,00 US$
No. of employees
312
Open
12,90 US$
High
13,17 US$
Low
12,47 US$
Mkt. cap
1,68 მლრდ.
Avg. vol.
1,04 მლნ.
Volume
632,20 ათ.
52-wk high
22,67 US$
52-wk low
11,00 US$
No. of employees
312
News stories
From web sources and news partners
The Globe and Mail
·
19 წუთის წინ
The S&P 500 Just Fell More Than 4% in a Day From Near Its Record. Here's What Happened Next in 2 Similar Situations Since 1950.
巴士的報
·
53 წუთის წინ
U.S. stocks close mixed as chip rebound
Fox Business
·
5 საათის წინ
Nasdaq rallies as chip stocks recover from brutal losses
Investor's Business Daily
·
2 საათის წინ
Battered Market Needs Repair, These Big Winners Look Broken
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersSomerville, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitegeneratebiomedicines.com